ECDC recommends multipronged effort to combat MCR-1 resistance
The MCR-1 resistance gene, which has now been detected in at least 20 countries and renders bacteria resistant to the last-resort antibiotic colistin, poses a "substantial public health risk" to the European Union and must be combatted on a range of fronts, the European Centre for Disease Prevention and Control (ECDC) said today in its latest rapid risk assessment.